À¯¹æ¾Ï °ËÁø¿¡ À¯¹æÁ¶¿µ¼ú°ú ÃÊÀ½ÆÄ°Ë»çÀÇ È¿°ú¼º°ú ¾ÈÁ¤¼º ºñ±³¿¬±¸
ÀÓ»óÁú¹®
|
À¯¹æ¾Ï ½ºÅ©¸®´×¿¡ À¯¹æÁ¶¿µ¼ú°ú ÇÔ²² ÃÊÀ½Æİ˻縦 ½ÃÇàÇÏ´Â °ÍÀÌ ÀÇ¹Ì ÀÖ½À´Ï±î?
|
±Ù°Å±â¹Ý ´äº¯
|
À¯¹æ¾Ï ½ºÅ©¸®´×À» À§ÇØ À¯¹æÁ¶¿µ¼ú(mammography)°ú ÇÔ²² º¸Á¶ÀûÀ¸·Î ÃÊÀ½ÆÄ°Ë»ç(ultrasonography)¸¦ ½ÃÇàÇÒ ¶§¿Í À¯¹æÁ¶¿µ¼ú¸¸ ½ÃÇàÇÒ ¶§ÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» ºñ±³Æò°¡Çϱâ À§ÇØ ¸®ºä ¿¬±¸¸¦ ½ÃÇàÇÑ °á°ú, À¯¹æ¾Ï À§ÇèÀÌ Æò±Õ ¼öÁØÀÎ ¿©¼ºÀÇ À¯¹æ¾Ï ½ºÅ©¸®´×¿¡¼ À¯¹æÁ¶¿µ¼úÀÇ º¸Á¶ °Ë»ç·Î ÃÊÀ½ÆÄ°Ë»çÀÇ ·çƾ ÀÌ¿ëÀ» Á¤´çÈ ÇØ ÁÖ´Â Áõ°Å´Â ¾ø½À´Ï´Ù.
|
¼ÁöÁ¤º¸
|
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database of Systematic Reviews 2013, Issue 4. DOI: 10.1002/14651858.CD009632.pub2
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009632.pub2/abstract
|
¿¬±¸¸ñÀû
|
À¯¹æ¾Ï°ËÁø¿¡¼ À¯¹æÁ¶Çü¼ú ´Üµ¶ °Ë»ç¿Í À¯¹æÁ¶Çü¼ú°ú ÃÊÀ½Æĸ¦ º´¿ëÇÒ ¶§ ¾ÈÁ¤¼º°ú È¿°ú¼ºÀ» ºñ±³Çϱâ À§ÇÔ.
|
¿¬±¸¼³°è
|
ü°èÀû °íÂû(Systematic Review)
|
¿¬±¸´ë»ó
|
40~75¼¼ »çÀÌÀÇ À¯¹æÀÌ Æò±ÕÀ§Çè ¼öÁØÀÎ ¿©¼º, 1,000¸íÀ» ´ë»ó
|
½ÃÇ豺 ÁßÀç
|
mammography screening
|
´ëÁ¶±º ÁßÀç
|
mammography screening with additional breast ultrasonography
|
Æò°¡ÁöÇ¥
|
1Â÷ Æò°¡ÁöÇ¥ : À¯¹æ¾Ï »ç¸Á·ü
2Â÷ Æò°¡ÁöÇ¥ : All-cause mortality• Incremental cancer detection rate• Incremental detection rate of invasive cancers• Rate of interval cancers• Lymph node status• Size of detected cancers• Health-related quality of life• False positive rate• False negative rate• Rate of biopsies• Screening associated harm (psychological distress, adverse effects caused by subsequent diagnostic or therapeutic interventions, others)
|
ÁÖ¿ä°á°ú
|
ÃÑ 2,731 citationsÀ» ºÐ¼®ÇÏ¿´À¸³ª, ÀϺ»¿¡¼ 1ÆíÀÇ ³í¹®ÀÌ RCT·Î ÁøÇàµÇ°í ÀÖÀ¸³ª ³ª¸ÓÁö ¿¬±¸µéÀº À¯¹æ¾Ï À§ÇèÀÌ Æò±Õ ¼öÁØÀÎ ¿©¼ºÀÇ À¯¹æ¾Ï ½ºÅ©¸®´×¿¡¼ À¯¹æÁ¶¿µ¼úÀÇ º¸Á¶ °Ë»ç·Î ÃÊÀ½ÆÄ°Ë»çÀÇ ·çƾ ÀÌ¿ëÀ» Á¤´çÈ ÇØ ÁÖ´Â Áõ°Å´Â ¾øÀ½.
|
±Ù°Å¼öÁØ
|
¸Å¿ì ³·À½
|
ÀÛ¼ºÀÚ
|
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC)
Copyright © 2017 Medical Research Information Center (MedRIC) Editors
|